EDGAR Filing Documents for 0001558370-22-004958

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-22-004958

Filing Date

2022-03-31

Accepted

2022-03-31 17:10:25

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	nrbo-20211231x10k.htm iXBRL	10-K	2670048
2	EX-10.47	nrbo-20211231xex10d47.htm	EX-10.47	31082
3	EX-10.48	nrbo-20211231xex10d48.htm	EX-10.48	37185
4	EX-21.1	nrbo-20211231xex21d1.htm	EX-21.1	4520
5	EX-23.1	nrbo-20211231xex23d1.htm	EX-23.1	4343
6	EX-31.1	nrbo-20211231xex31d1.htm	EX-31.1	15736
7	EX-32.1	nrbo-20211231xex32d1.htm	EX-32.1	8697
8	GRAPHIC	nrbo-20211231x10k001.jpg	GRAPHIC	3812
9	GRAPHIC	nrbo-20211231x10k002.jpg	GRAPHIC	13356
10	GRAPHIC	nrbo-20211231x10k003.jpg	GRAPHIC	26380
11	GRAPHIC	nrbo-20211231x10k004.jpg	GRAPHIC	12765
12	GRAPHIC	nrbo-20211231x10k005.jpg	GRAPHIC	10099
13	GRAPHIC	nrbo-20211231x10k006.jpg	GRAPHIC	45425
14	GRAPHIC	nrbo-20211231x10k007.jpg	GRAPHIC	20847
15	GRAPHIC	nrbo-20211231x10k008.jpg	GRAPHIC	17563
16	GRAPHIC	nrbo-20211231x10k009.jpg	GRAPHIC	6495
17	GRAPHIC	nrbo-20211231xex10d47002.jpg	GRAPHIC	1881
18	GRAPHIC	nrbo-20211231xex10d48002.jpg	GRAPHIC	1881
	Complete submission text file	0001558370-22-004958.txt		9151661

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	nrbo-20211231.xsd	EX-101.SCH	54973
20	EX-101.CAL	nrbo-20211231_cal.xml	EX-101.CAL	52662
21	EX-101.DEF	nrbo-20211231_def.xml	EX-101.DEF	229388
22	EX-101.LAB	nrbo-20211231_lab.xml	EX-101.LAB	526901
23	EX-101.PRE	nrbo-20211231_pre.xml	EX-101.PRE	394464
81	EXTRACTED XBRL INSTANCE DOCUMENT	nrbo-20211231x10k_htm.xml	XML	1296490

Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116

Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600

NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)